Latest Spinal stenosis Stories
Studies suggest that at least 80% of people will suffer from a spine problem at some point in their lives and of those who have lumbar spine surgery, failed back syndrome can affect as many as 10 to 40 percent of patients. Dr. Kaixuan Liu, founder of Atlantic Spine Center in New Jersey, offers tips and suggestions for patients who’ve had a failed back or failed neck surgery. Edison, NJ (PRWEB) July 26, 2012 How to reduce the chances of failed back surgery syndrome or failed neck...
ROCKVILLE, Md., July 25, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the seventeenth patient was treated in the ongoing Phase I trial of its spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). This patient is also the second to return to the trial for additional injections. In this treatment, the patient received five injections in the cervical (upper back) region of the spinal cord, in addition to...
FARMINGDALE, N.Y., July 12, 2012 /PRNewswire/ -- Misonix, Inc. (NasdaqGM: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, has announced its participation in the Cleveland Spine Review; Hands-On Course 2012, presented by the Cleveland Clinic Center for Spine Health,...
Dr. Michael Gleiber, a Board Certified, Fellowship Trained Spinal Surgeon in South Florida, is honored by Becker's Spine Review as having one of The Top 50 Spine Surgery Practices To Know in America. Dr. Gleiber specializes in the latest minimally invasive and motion preserving spinal procedures. Jupiter, Florida (PRWEB) July 03, 2012 Michael A. Gleiber, MD, is the founding partner and president of his spine surgery practice which includes locations in Jupiter and Boca Raton, Florida....
ROCKVILLE, Md., June 19, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patient to receive stem cell transplantation in both regions of the spinal cord has been treated in the ongoing Phase I trial of its spinal cord neural stem cells in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). This is also the 16th patient to be treated in the trial altogether and the first patient returning to the trial for a second treatment. In this treatment,...
KIRKLAND, Wash., June 14, 2012 /PRNewswire/ -- Dr. Ray Baker, medical director of the EvergreenHealth Spine and Musculoskeletal Program, was recently chosen as a member of a select group of specialists, "150 Pain Management Physicians to Know," by Becker's ASC (Ambulatory Service Centers) Review. Physicians in this elite group were selected for their noteworthy contributions to the field of pain management, positions at top healthcare institutions and affiliation with professional...
NEW YORK, June 14, 2012 /PRNewswire/ -- Paradigm Spine, LLC, a leading provider of non-fusion "surgeon-centric" spinal implant technologies, announces the release of key findings based on its landmark coflex® IDE study. In a podium presentation titled "Coflex® Interlaminar Stabilization Compared to Posterior Spinal Fusion", the Company highlights its study of the safety and efficacy of the coflex® interlaminar device compared to posterior spinal fusion. The study was a...
New stem cell therapy program using the in SRT injection is a state-of-the-art spinal and joint rejuvenation procedure that is minimally invasive, fast to implement, and highly successful. Orange, CA (PRWEB) June 07, 2012 Dr. Thaiyananthan, also known as “Dr. Ty,” has become the first American surgeon to use inSRT stem cell therapy to treat spine diseases and joint pain. Dr. Ty, founder of the Brain and Spine Institute of California, and Dr. Tim Brahm, founder of BioDLogics,...
ROCKVILLE, Md., June 5, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the Emory University Institutional Review Board (IRB) approved the amendment to the ongoing Phase I trial evaluating Neuralstem's spinal cord stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The amendment permits the return of three previously-treated patients to the trial to receive additional injections of cells. This modification to the...
Even at 80 or older, age shouldn't be a barrier to surgery for 'C2' fractures For older adults with "C2" fractures of the upper (cervical) spine, surgery and nonsurgical treatment provide similar short- and long-term outcomes, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. Although the patients were at significant risk of complications and death in the year or two after C2 fracture, these risks are similar with surgical and...
